Eli Lilly said Monday it will spend up to $7 billion to buy privately held Kelonia Therapeutics for its suite of cancer treatments.

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.

Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...

Honda is recalling 440,830 Honda Odysseys from 2018 to 2022. Honda is recalling over 440,000 minivans due to issues with ...

Researchers highlighted how an arginine- and proline-restricted diet combined with eflornithine reprogrammed MYCN-driven ...

Add Yahoo as a preferred source to see more of our stories on Google. Glioblastoma remains one of the toughest cancers to treat. Its aggressive spread makes surgery difficult. (CREDIT: Shutterstock) ...

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialized immune cells. The discovery, published in ...

A new platform enables fast, scalable protein evolution - opening the door to new therapies and diagnostics, and to predicting resistance mutations across many disease areas. (Nanowerk News) In ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding off-target effects, immune activation, and unnecessary drug exposure. (Nanowerk ...

A new study led by researchers at Huntsman Cancer Institute at the University of Utah (the U) shows that regular exercise may do more than help colon cancer patients feel better—it may actually change ...